pCAG-VSVL Citations (10)
Originally described in: Genetic Neuroengineering Group PlasmidsUnpublished
Articles Citing pCAG-VSVL
| Articles |
|---|
| Susceptibility of rabbits to SARS-CoV-2. Mykytyn AZ, Lamers MM, Okba NMA, Breugem TI, Schipper D, van den Doel PB, van Run P, van Amerongen G, de Waal L, Koopmans MPG, Stittelaar KJ, van den Brand JMA, Haagmans BL. Emerg Microbes Infect. 2021 Dec;10(1):1-7. doi: 10.1080/22221751.2020.1868951. PubMed |
| SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. Mykytyn AZ, Breugem TI, Riesebosch S, Schipper D, van den Doel PB, Rottier RJ, Lamers MM, Haagmans BL. Elife. 2021 Jan 4;10. pii: 64508. doi: 10.7554/eLife.64508. PubMed |
| Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. Hennrich AA, Sawatsky B, Santos-Mandujano R, Banda DH, Oberhuber M, Schopf A, Pfaffinger V, Wittwer K, Riedel C, Pfaller CK, Conzelmann KK. PLoS Pathog. 2021 Apr 21;17(4):e1009064. doi: 10.1371/journal.ppat.1009064. eCollection 2021 Apr. PubMed |
| Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs. Kazemi S, Lopez-Munoz AD, Holly J, Jin L, Yewdell JW, Dolan BP. bioRxiv. 2021 Oct 22. doi: 10.1101/2021.10.21.465386. PubMed |
| In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2. Mulgaonkar N, Wang H, Mallawarachchi S, Ruzek D, Martina B, Fernando S. J Biomol Struct Dyn. 2022 Feb 26:1-10. doi: 10.1080/07391102.2022.2045221. PubMed |
| Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. Kazemi S, Lopez-Munoz AD, Holly J, Jin L, Yewdell JW, Dolan BP. J Virol. 2022 Sep 14;96(17):e0025622. doi: 10.1128/jvi.00256-22. Epub 2022 Aug 24. PubMed |
| Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. Li M, Du J, Liu W, Li Z, Lv F, Hu C, Dai Y, Zhang X, Zhang Z, Liu G, Pan Q, Yu Y, Wang X, Zhu P, Tan X, Garber PA, Zhou X. ISME J. 2023 Apr;17(4):549-560. doi: 10.1038/s41396-023-01368-2. Epub 2023 Jan 23. PubMed |
| Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines. Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL, Orr AG. Sci Adv. 2023 Apr 21;9(16):eade1282. doi: 10.1126/sciadv.ade1282. Epub 2023 Apr 19. PubMed |
| Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both. Beitari S, Agbayani G, Hewitt M, Duque D, Bavananthasivam J, Sandhu JK, Akache B, Hadzisejdic I, Tran A. Sci Rep. 2023 Dec 4;13(1):21390. doi: 10.1038/s41598-023-48397-7. PubMed |
| Transgenic tools targeting the basal ganglia reveal both evolutionary conservation and specialization of neural circuits in zebrafish. Tanimoto Y, Kakinuma H, Aoki R, Shiraki T, Higashijima SI, Okamoto H. Cell Rep. 2024 Mar 26;43(3):113916. doi: 10.1016/j.celrep.2024.113916. Epub 2024 Mar 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.